Showing results (271-280 of 395) with videos related to

Sort By:
Pageof 40
Blood|September 28, 2006
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemiaAlbert Moghrabi, Donna E Levy, Barbara Asselin, et al.
JCO Precision Oncology|January 18, 2024
Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) TrialIan E Krop, Lorenza Mittempergher, Joseph N Paulson, et al.
Clinical Breast Cancer|July 25, 2008
A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37Irene L Wapnir, Stefan Aebi, Charles E Geyer, et al.
Leukemia|February 24, 2001
Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)L B Silverman, L Declerck, R D Gelber, et al.
Breast Cancer Research and Treatment|October 28, 2008
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93Olivia Pagani, Shari Gelber, Edda Simoncini, et al.
Cancer|October 22, 1998
The importance of the histologic grade of invasive breast carcinoma and response to chemotherapyS E Pinder, S Murray, I O Ellis, et al.
The New England Journal of Medicine|June 6, 2017
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast CancerGunter von Minckwitz, Marion Procter, Evandro de Azambuja, et al.
Anticancer Research|February 4, 2019
Autoimmunity and Benefit from Trastuzumab Treatment in Breast Cancer: Results from the HERA TrialAmir Sonnenblick, Andrew Bailey, Beatrice Uziely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocolSteven E Lipshultz, Amy L Giantris, Stuart R Lipsitz, et al.
Breast Cancer Research and Treatment|November 7, 2020
Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trialManuela Rabaglio, Zhuoxin Sun, Rudolf Maibach, et al.
Pageof 40